Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection

A.F. Hirschfeld; J.A. Bettinger; R.E. Victor; D.J. Davidson; A.J. Currie; J.M. Ansermino; D.W. Scheifele; J.S. Orange; S.E. Turvey

doi:10.1016/j.clim.2006.10.012

Back

Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection

Journal article

Peer reviewed

Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection

A.F. Hirschfeld, J.A. Bettinger, R.E. Victor, D.J. Davidson, A.J. Currie, J.M. Ansermino, D.W. Scheifele, J.S. Orange and S.E. Turvey

Clinical Immunology, Vol.122(3), pp.271-278

2007

DOI: https://doi.org/10.1016/j.clim.2006.10.012

Files and links (1)

url

Link to Published Version *Subscription may be requiredView

Abstract

Human primary immunodeficiencies affecting Toll-like receptor (TLR) signalling reveal a non-redundant role for TLR function in defense against pneumococcal infection. To determine the clinical relevance of TLR abnormalities, we studied a population predicted to be enriched for TLR defects-healthy children who had developed invasive pneumococcal infection in the absence of classic risk factors for infection. We describe the development and optimization of a peripheral blood TLR assay. By testing 38 healthy control neonates, children and adults we demonstrated that TLR function was stable over the first six decades of life. We tested 50 children with a history of invasive pneumococcal infection and although TLR defects were predicted to be over-represented in this population, we did not identify any TLR abnormalities. Although TLR signalling defects are associated with greatly enhanced susceptibility to invasive pneumococcal infection, our results suggest that routine clinical screening for TLR defects in healthy children who develop invasive pneumococcal infection is not justified.

Details

Title: Prevalence of Toll-like receptor signalling defects in apparently healthy children who developed invasive pneumococcal infection
Authors/Creators: A.F. Hirschfeld (Author/Creator) - BC Children's Hospital
J.A. Bettinger (Author/Creator) - BC Children's Hospital
R.E. Victor (Author/Creator) - BC Children's Hospital
D.J. Davidson (Author/Creator) - Centre for Inflammation Research
A.J. Currie (Author/Creator) - The University of Western Australia
J.M. Ansermino (Author/Creator) - BC Children's Hospital
D.W. Scheifele (Author/Creator) - BC Children's Hospital
J.S. Orange (Author/Creator) - Children's Hospital of Philadelphia
S.E. Turvey (Author/Creator) - BC Children's Hospital
Publication Details: Clinical Immunology, Vol.122(3), pp.271-278
Publisher: Academic Press Inc.
Identifiers: 991005544102507891
Copyright: © 2006 Elsevier Inc.
Murdoch Affiliation: Murdoch University
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

26 Record Views

27 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.6 Immunology; 1.6.609 Toll-like Receptors
Web Of Science research areas: Immunology
ESI research areas: Immunology